Abingdon, United Kingdom

Ana Pereira Ribeiro

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunocore Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ana Pereira Ribeiro. Retrieved from https://idiyas.com/inventor/ana-pereira-ribeiro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Ana Pereira Ribeiro

Introduction

Ana Pereira Ribeiro is a notable inventor based in Abingdon, GB. She has made significant contributions to the field of biotechnology, particularly in the development of binding molecules for therapeutic applications. Her work focuses on innovative solutions for treating malignant diseases.

Latest Patents

Ana holds a patent for her invention titled "Binding molecules." This invention relates to binding molecules that comprise T cell receptor (TCR) variable domains, which can bind to a PIWIL1 peptide-HLA complex. The implications of this invention are profound, as it offers potential avenues for the treatment of various malignant diseases.

Career Highlights

Ana Pereira Ribeiro is currently associated with Immunocore Limited, a company known for its pioneering work in immunotherapy. Her role at the company allows her to leverage her expertise in developing novel therapeutic strategies.

Collaborations

Ana has collaborated with talented individuals such as Nicole Mai and Arnaud Techine. These collaborations enhance the innovative potential of her work and contribute to the advancement of research in her field.

Conclusion

Ana Pereira Ribeiro's contributions to biotechnology through her innovative patents and collaborations highlight her role as a leading inventor in the industry. Her work continues to pave the way for advancements in the treatment of malignant diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…